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doi:10.1016/j.gmbhs.2012.04.001Abstract A systemic approach was used to identify the possible mechanisms underlying the
development of 5-fluorouracil (5FU)-induced resistance on HCT116 colon cancer cells. From
microarray analysis, HCT116 high-dose 5FU-resistant subclones showed differential gene
expression compared to HCT116-sensitive clones. According to gene ontology, and Kyoto Ency-
clopedia of Genes and Genomes pathways, the up-regulated genes were related to cell death
and lupus erythematosus, respectively. On the other hand, the down-regulated genes were
related to cell division or DNA replication. Connectivity map (cMAP) analysis revealed that
the molecular drugs, such as antiasthmatic or antiallergy agents that have negative correla-
tions with cMAP score, may have beneficial effect for the resistant subclones. Our findings sug-
gested that the feasibility of cMAP combining microarray gene expression profile may help
identify a potential drug that possibly will reverse the effect of 5FU-induced resistance.
Copyright ª 2012, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Colon cancer is the third most frequently diagnosed cancer1
and also the third leading cause of cancer deaths innstitute of Systems Biology
niversity, 300 Jung-Da Road,
(L.-J. Su).
an Genomic Medicine and BiomaTaiwan.2 Commonly, 5-fluorouracil (5FU) is the first choice
in the treatment of colon cancer3; however, long-term
exposure of 5FU to cancer cells may result in chemo-
resistant phenotype.4 The reasons why cancer treatment
becomes ineffective over periods of time is unknown;
however, it has been found that cancer cells become resis-
tant through the mechanisms of alteration of drug’s specific
target, drug inactivation, influx and efflux of drugs in the
cells, drug-induced damage, and evasion of apoptosis.5rker Society. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Effect of 5FU on the viability of HCT116-sensitive and HCT116-resistant cells. (A) Morphology of HCT116-, SW480-, and
SW620-sensitive cells undermicroscopeafter 5days. HCT116 cellswerenaturally sensitive to 5FU, and thuswere chosenand trained to
become 5FU resistant. SW-sensitive cells were naturally resistant to 5FU and thus were not chosen for this study. (B) Proliferative
activity of the cells was treatedwith 0, 2, 5, 30, 60, 90, and 120 mM of 5FU assessed byMTTassay. The inhibitory effect of 5FUwas dose
-dependent. 5FUZ 5-fluorouracil.
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Table 1 IC50 of HCT116-sensitive and HCT116-resistant
clones.
Clones IC50 (mM)
Sensitive 3
Resistant
Lw-5FU 3
Hi-5FU1 60
Hi-5FU2 180
IC50 Z half maximal inhibitory concentration; 5FU Z 5-
fluorouracil.
Mechanistic study of HCT116 resistant clones 23Microarray technology and the associated databases
provide a high throughput method for identifying differ-
entially expressed gene profiles. In this study, two kinds of
databases, gene ontology (GO) and Kyoto Encyclopedia of
Genes and Genomes (KEGG), were used for biological
processes and pathways analysis, respectively. Connectivity
map (cMAP) was used as a useful tool for the identification
of any drugs that may have beneficial effects on the resis-
tant subclones.
In the present report, we have successfully cultured
HCT116 resistant subclones and, when performing cell
viability assay (MTT), we proved that Hi-5FU1 and Hi-5FU2
were resistant toward high concentrations of 5FU. Using
microarray technology, the differential gene expression
reveals possible mechanisms that are related to chemo-
resistance, and, hopefully, the potential drugs identifiedFigure 2 Correlation coefficient analysis between gene expres
showed good reproducibility within each treatment group.from cMAP can reverse the resistance of HCT116 subclones
and become the candidate drug for combined therapy in
cancer retreatment.Materials and methods
Cell lines and culture
The colon cancer cell lines HCT116 were maintained in
McCoy’s 5A medium supplemented with 10% fetal bovine
serum (FBS). Cells were cultured at 37C in a humidified
atmosphere of 5% CO2:95% air. Three subclones of HCT116
(Lw-5FU1, Lw-5FU2, and Lw-5FU3), which are resistant to
2 mM of 5FU, and two subclones of HCT116 (Hi-5FU1, Hi-
5FU2, and Hi-5FU3), which are resistant to 50 mM of 5FU,
were used in this study. The resistant subclones were
generated by adding 2 and 50 mM of 5FU continuously over
a period of time.MTT assay
The protocol was described by Kang et al.6 In brief, cells
were plated at 3  103/200 mL in 96-well plates in McCoy’s
5A with 10% FBS and allowed to attach overnight. Then the
medium was replaced with varying concentrations (0, 2, 10,
30, 60, 90, 120, and 300 mM) of 5FU. After 5 days of expo-
sure, the number of viable cells in each well was estimatedsion profiles. Nine samples from the three treatment groups
24 A.H. Tseng et al.by adding 10 mL of MTT solution and incubated for 5 hours at
37C. All assays were performed in triplicates.
Processing of microarray chips
Total RNA was extracted using Illustra TriplePrep kit (GE
Healthcare, Buckinghamshire, UK) from cells treated with
or without 5FU, according to the manufacturer’s protocol.
Concentration and purity of RNA were determined using
Nanodrop 2000 (Thermo Scientific, Wilmington, DE, USA).
The gene expression data were generated using Affymetrix
Human Genome U133 Plus 2.0 arrays (Affymetrix, Santa
Clara, CA, USA). The cRNA synthesis and labeling were
carried out according to Affymetrix GeneChip protocol
(Affymetrix), and arrays were scanned with Affymetrix
GeneChip 3000 7G (Affymetrix).
Quality assessment of the microarray data and
identification of differentially expressed genes
The log2-transformed expression intensities with robust
multichip average (RMA) normalization from nine micro-
arrays were used to calculate the correlation coefficient in
each cluster set, and a heatmap was constructed. TheFigure 3 Two-dimensional hierarchical clustering analysis of gene
(Hi-5FU), compared to control. This heatmap is divided into three c
regulated, based on the expression level in the 50 mM 5FU cluster.genes differentially expressed in this study were selected
using R language bioconductor. The t test p value and fold
change comparing the treatment and control group were
calculated. A p value of greater than 0.01 and a fold change
of greater than 3 were removed, and the remaining was
considered as differentially expressed.Identification of biological processes and pathways
enriched with differentially expressed genes
The list of differentially expressed genes was imported to
GO (http://www.geneontology.org/) and KEGG (http://
www.genome.jp/kegg/) databases. The biological
processes and pathways enriched with the differentially
expressed genes were according to p values.cMAP analysis
Hi-5FU2 was analyzed using cMAP in an attempt to link
genes associated with therapeutic agents. The imported
query was compared with predefined signatures of thera-
peutic compounds and ranked according to the connectivity
score (þ1 to e1).7s that were treated with 2 mM of 5FU (Lw-5FU) and 50 mM of 5FU
lusters: down-regulated, up-regulated, and intermediate down-
5FU Z 5-fluorouracil.
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Effect of 5FU on proliferative activity of HCT116-
sensitive and HCT116-resistant cells
HCT116 cells were selected for resistance training because
it is more sensitive to 5FU than other colon cancer typesTable 2 Top GO and KEGG pathways with respect to differenti
Cluster GO p
Up-regulated
Nucleosome assembly 4.92Ee
DNA packaging 0.0001
DNA damage response 0.0001
Death 0.0002
Chromatin assembly or disassembly 0.0003
Regulation of programmed cell death 0.0005
Induction of apoptosis by intracellular signals 0.0006
Induction of programmed cell death 0.0025
Negative regulation of cell death 0.0025
Regulation of cell cycle arrest 0.0029
Down-regulated
Organelle fission 8.63Ee
Cell division 6.90Ee
M phase 1.13E
Mitotic cell cycle 2.44E
Mitosis 8.39E
Chromosome segregation 5.43E
DNA replication 1.01E
Cellular component organization 1.06E
Cell cycle 2.55E
Chromosome organization 6.66E
Intermediate down-regulated
Epidermis development 1.91E
Organ development 5.69E
Regulation of hippo signaling cascade 0.0001
Positive regulation of endothelial cell migration 0.0001
Release of cytochrome c from mitochondria 0.0001
Localization of cell 0.0001
Regulation of cell adhesion 0.0001
Response to biotic stimulus 0.0002
Blood vessel development 0.0003
Negative regulation of plasminogen activation 0.0003
GO Z gene ontology; KEGG Z Kyoto Encyclopedia of Genes and Gensuch as SW480 and SW620 (Fig. 1A). To prove that HCT116-
resistant subclones were obtained successfully, treatments
of HCT116-sensitive and HCT116-resistant cells were
tested using MTT assay (Fig. 1B). At 2 mM of 5FU, the cell
viability of HCT116-sensitive and Lw-5FU had decreased to
20% and 15%, respectively. With the increase in concen-
trations of 5FU, the inhibition of cell growth reached 100%.ally expressed genes.
KEGG pathways p
06 Systemic lupus erythematosus 5.62Ee06
2 P53 signaling pathway 2.92Ee05
7 Bladder cancer 0.00306
4 Vitamin B6 metabolism 0.00332
1 Chronic myeloid leukemia 0.00724
6 Pathways in cancer 0.01007
0
6
8
2
61 Cell cycle 1.26Ee23
51 DNA replication 2.93Ee18
e50 Oocyte meiosis 8.27Ee09
e38 Mismatch repair 2.11Ee07
e38 Progesterone-mediated oocyte maturation 3.82Ee07
e26 Base excision repair 6.63Ee05
e17 One carbon pool by folate 0.00015
e16 Pyrimidine metabolism 0.00021
e12 Nucleotide excision repair 0.00044
e12 Colorectal cancer 0.00075
P53 signaling pathway 0.00139
Homologous recombination 0.00148
Citrate cycle 0.00206
Glycine, serine, and threonine metabolism 0.00280
Cysteine and methionine metabolism 0.00372
Bacterial invasion of epithelial cells 0.00635
Pathogenic Escherichia coli infection 0.00730
Cyano amino acid metabolism 0.01945
Metabolic pathways 0.02041
Pathways in cancer 0.03033
Synthesis and degradation of ketone bodies 0.03196
Peroxisome 0.03474
Folate biosynthesis 0.04682
e05 P53 signaling pathway 3.43Ee06
e05 Renal cell carcinoma 0.00441
1 Hypertrophic cardiomyopathy 0.00813
2 Glycerolipid metabolism 0.01122
4 Focal adhesion 0.01152
6 Adipocytokine signaling pathway 0.02627
8 Complement and coagulation cascades 0.02732
0 Chronic myeloid leukemia 0.03288
1 B-cell receptor signaling pathway 0.03648
2 Pathways in cancer 0.03677
TGF-beta signaling pathway 0.04563
Small cell lung cancer 0.04844
omes; TGF Z transforming growth factor.
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dose dependent. At a dose of 300 mM 5FU, Hi-5FU1 and
Hi-5FU2 still maintained its resistance and reached an
inhibition level of 60e70%. Both Hi-5FU1 and Hi-5FU2
subclones possess high resistance with a half maximal
inhibitory concentration (IC50) of 60 and 180 mM (Table 1),
respectively.Quality assessment of microarray data
Hierarchical clustering analysis was used to assess the
quality of the microarray data. There is a high correlation
between the gene expression profiles in each group (Fig. 2),
based on Pearson correlation. This satisfactory result
warrants further analysis.
The heatmap was divided into three groups: up-
regulated, down-regulated, and intermediate down-
regulated, according to color indication in high-dose 5FU
cluster (Fig. 3). The three groups clustered tightly together
and showed dramatically differential expression compared
to control groups.Biological process analysis in GO
To analyze the biological relevance of each cluster, the
differentially expressed genes were grouped into GO
(Table 2). In the up-regulated cluster, most of the genes are
related to cell death at p< 0.05. Ten enriched biological
processes were found in down-regulated cluster. Most of
the processes are related to cell division or mitosis cell
cycle.Table 3 Results of cMAP query of the top 20 negatively correla
Rank cMAP name Dose Cell
1 Zaprinast 15 mM HL60
2 Acetazolamide 18 mM PC3
3 Riluzole 15 mM PC3
4 Atractyloside 5 mM HL60
5 Lansoprazole 11 mM HL60
6 Vinblastine 100 nM MCF7
7 Harmol 16 mM HL60
8 Diethylstilbestrol 15 mM HL60
9 Podophyllotoxin 10 mM MCF7
10 Mafenide 18 mM HL60
11 Fludrocortisone 9 mM HL60
12 Diphenhydramine 14 mM HL60
13 Proguanil 14 mM HL60
14 Ioxaglic acid 3 mM MCF7
15 Midodrine 14 mM HL60
16 Aciclovir 18 mM HL60
17 BCB000040 10 mM MCF7
18 Fulvestrant 10 nM HL60
19 Monorden 100 nM HL60
20 Mimosine 20 mM MCF7
cMAP Z connectivity map.Pathway analysis in KEGG database
There were 12 differentially expressed genes in the up-
regulated cluster, which were involved with systemic lupus
erythematosus and P53 signaling pathway. The pathways
related to cell cycle or DNA replication were down-
regulated in high-dose 5FU subclones. Comparing all the
KEGG pathways in all three of the clusters listed in Table 2,
most of the pathways were related to P53 signaling
pathway, cell deaths, and cell cycle.
Gene expression profile and cMAP analysis
cMAP is an approach that compares the lists of gene
expression profiles to the library of experiments
assessing the effect of small molecules and genetic
events on gene expression.8 According to the query
results, 20 negatively correlated drugs were identified
(Table 3). We suspected that the drugs may have the
potential to reverse the resistant subclones into its
naive state. However, whether these agents may have
beneficial effects on resistant subclones is still under
investigation.
Discussion
Chemoresistance has posed several problems for patients
who rely on chemotherapeutic drugs for cancer treatment.
Based on microarray technologies, we integrated the
differential gene expression data with computational
approaches to identify pathways and rational drugs that
may reverse the effect of chemoresistance. All theted drugs based on cMAP score.
Score Therapeutic uses
1 Antiasthmatic, antiallergic
0.932 Diuretic, anticonvulsant
0.921 Anti-ischemic, anticonvulsant, antianxiety,
hypnotic, anesthetic, psychotropic agent
0.906
0.904 Gastrointestinal agent
0.902 Antineoplastic
0.898
0.896 Antineoplastic, vasodilator, hormonal agent
0.889 Antineoplastic
0.882 Antibacterial
0.882
0.876 Antihistamine
0.869
0.865
0.864 Vasoconstrictor
0.863 Antiviral
0.858
0.858
0.858
0.849 Antiproliferative
Mechanistic study of HCT116 resistant clones 27subclones were first tested for their resistance. The Hi-
5FU1 and Hi-5FU2 clearly showed that they have high
resistance toward 5FU.
Nine samples of array data were analyzed for quality
assessment. The correlation within each data set has high
correlations, indicating that there is a high reproducibility
in the microarray experiment. The clusters showed
different expression profiles when comparing high- and low-
resistant subclones with control. In GO, most of the down-
regulated genes in high-resistant clones were related to
organelle fission and cell division. This finding supports our
observation of slow growth of Hi-5FU1 and Hi-5FU2 in the
laboratory.
Most of the up-regulated genes in our high-resistant
sub-clones were related to death, and we suspect that it
is related to autophagy since a study has demonstrated
that the resistance of cells is associated with the switch
from apoptosis to autophagy cell death.9 The pathways
related to down-regulated genes were mainly cell cycle
or DNA replication, which correlates with the finding on
GO. Whether the pathways in the up-regulated gene
cluster were involved with lupus erythematosus is now
under investigation in our laboratory. The molecular
effect of potential drugs from cMAP query is important
for cancer therapies. However, whether these drugs can
potentiate the cancer cell resistance still awaits further
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